CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 10 No. 6
 

Severity of Hot Flashes Worse in Breast Cancer Survivors

June 1, 2001

PONTE VEDRA BEACH, Fla—Breast cancer survivors experienced significantly worse hot flashes, compared with age-matched healthy women, in a Vanderbilt University study. The Research also raised doubts about the accuracy of hot flash reports in patient diaries.

Janet S. Carpenter, PhD, RN, assistant professor, Vanderbilt University School of Nursing, and deputy director for the Research Team on Cancer Pain and Symptom Management at the Vanderbilt-Ingram Cancer Center, presented the research at the Oncology Nursing Society’s Sixth National Conference on Cancer Nursing Research.

"We found that breast cancer survivors’ hot flashes were more frequent and more severe, lasted longer, and interfered more with quality of life, " she told ONI in an interview.

Breast cancer survivors and healthy women alike under-reported symptoms in the diaries, which are widely used by menopause researchers, Dr. Carpenter said.

Many women recorded far fewer hot flashes than the researchers documented using electrodes attached to the women’s skin (see Figure). In one case, a breast cancer survivor said she had seven hot flashes in a 24-hour period when a measuring device recorded 26 hot flashes.

"I don’t think diaries are accurate, and I don’t think menopause research to date is accurate because the researchers relied on these diaries," Dr. Carpenter said. She reported that, in her study, women slept through one or more hot flashes before waking up. Some had multiple flashes while driving, but only recorded one afterward.

The project focused on menopause symptoms because breast cancer treatment often causes early menopause, and survivors are generally precluded from taking hormone replacement therapy (HRT) to relieve symptoms. More than 65% of survivors have hot flashes, 59% rate them as severe, and 44% say they are extremely distressed by hot flashes, Dr. Carpenter said.

New Scale

In this study, Dr. Carpenter supplemented existing research tools with a new tool, the Hot Flash Related Daily Interference Scale (HFRDIS). It measures (as a score of 0 to 10) the effect of hot flashes on overall quality of life and on nine specific activities: work, social activities, leisure activities, sleep, mood, concentration, relations with others, sexuality, and enjoyment of life.

The study compared 69 breast cancer survivors with 63 healthy age-matched controls. Survivors were more likely to be postmenopausal.

The overall severity of the survivors’ hot flashes was almost three times as great: Their mean on a 1 to 10 scale was 3.84, compared with 1.35 for the controls. Analysis of a subset of 35 healthy women and 22 survivors who reached menopause naturally showed that the survivors scored overall severity more than twice as high: 3.23 vs 1.46.

Breast cancer survivors with moderate to severe hot flashes (overall severity rating of 5 or more) had a mean HFRDIS score measuring the effect of hot flashes on overall quality of life of 2.73, compared with 0.44 for breast cancer survivors with no or mildly severe hot flashes (overall severity rating less than 5) (see Table).

The survivor group included women who had received a variety of cancer treatments, Dr. Carpenter said. Some of the women were taking tamoxifen(Drug information on tamoxifen) (Nolvadex) at the time of the study. She suggested that the therapy was causing menopausal symptoms to become more severe, possibly by lowering hormone levels. "It’s not just hot flashes. It’s more negative mood, vaginal drying, tiredness, and body aches," she said.

More Research Urged

Dr. Carpenter urged more research into the effect of breast cancer treatments on menopausal symptoms. "This issue is getting more and more attention, but I think the severity of it isn’t recognized," she said.

The research is being funded by a joint grant from the Oncology Nursing Foundation and Sigma Theta Tau International Honor Society of Nursing. Support is also provided by the Vanderbilt University School of Nursing Joint Center for Nursing Research.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy